CURx Pharmaceuticals, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From CURx Pharmaceuticals, Inc.
At CHPA conference, IRI's lead for health care market data, Kristin Hornberger, said as manufacturers increase product prices in response to rising costs and inflationary pressures, they also should work to make their products more valuable to consumers.
The French group is sharpening its focus on specialty care
Response to sale of Unilever’s direct selling business in Thailand, Unilever Life, like its recent failed bid for GSK consumer and its elimination of 1,500 management staff, exposes disconnect between its priorities and its shareholders preferences.
Unilever, which has had three offers for GSK rebuffed, likely notes that the Federal Trade Commission and Department of Justice signal they will tighten scrutiny of deals that merge companies providing consumer-facing products and services.
- Specialty Pharmaceuticals